T-bet is a transcription factor that is essential for T helper (Th)1 lineage commitment and optimal IFN-␥ production by CD4 ϩ T cells. We examined the role of T-bet in the development of experimental crescentic glomerulonephritis, which is induced by Th1-predominant, delayed-type hypersensitivity-like responses directed against a nephritogenic antigen. Anti-glomerular basement membrane (GBM) glomerulonephritis was induced in T-bet Ϫ/Ϫ and wild-type C57BL/6 mice. Compared with wild-type controls, renal injury was attenuated in T-bet Ϫ/Ϫ mice with glomerulonephritis, evidenced by less proteinuria, glomerular crescents, and tubulointerstitial inflammation. Accumulation of glomerular CD4 ϩ T cells and macrophages was decreased, and was associated with reduced intrarenal expression of the potent Th1 chemoattractants CCL5/ RANTES and CXCL9/Mig. Supporting the pro-inflammatory nature of T-bet signaling, assessment of systemic immunity confirmed that T-bet Ϫ/Ϫ mice had a reduction in Th1 immunity. The kinetic profile of T-bet mRNA in wild-type mice supported the hypothesis that T-bet deficiency attenuates renal injury in part by shifting the Th1/Th2 balance away from a Th1 phenotype. Expression of renal and splenic IL-17A, characteristically expressed by the Th17 subset of effector T cells, which have been implicated in the pathogenesis of autoimmune disease, was increased in T-bet Ϫ/Ϫ mice. We conclude that T-bet directs Th1 responses that induce renal injury in experimental crescentic glomerulonephritis.
in wild-type mice supported the hypothesis that T-bet deficiency attenuates renal injury in part by shifting the Th1/Th2 balance away from a Th1 phenotype. Expression of renal and splenic IL-17A, characteristically expressed by the Th17 subset of effector T cells, which have been implicated in the pathogenesis of autoimmune disease, was increased in T-bet Ϫ/Ϫ mice. We conclude that T-bet directs Th1 responses that induce renal injury in experimental crescentic glomerulonephritis. The initial description of functionally distinct T helper (Th) cell subsets, Th1 and Th2, 1,2 has provided a useful framework for understanding various diseases. Th1 cells are characterized by the production of pro-inflammatory cytokines (IFN-␥, IL-2, and lymphotoxin-␣), mediate cellular immune responses, and play important roles in autoimmunity and clearance of intracellular organisms. In contrast, Th2 cells produce IL-4, IL-5, IL-10, and IL-13, and play an important role in allergy and clearance of helminth infections. Although the precise molecular mechanisms underlying Th1 development remain incompletely understood, the process is known to involve signals provided by the T cell receptor, costimulatory and chemokine-chemokine receptor signaling pathways 3 and the cytokine milieu at the time of antigen presentation (particularly IFN-␥, IL-12, and IL-18). 4 -8 Most recently, T helper cell subsets have been expanded to include Th17 cells, a distinct T helper cell lineage characterized by the production of IL-17 9 and implicated in the pathogenesis of autoimmune diseases, such as experimental autoimmune encephalomyelitis, 10 ,11 a model of multiple sclerosis, and collagen-induced arthritis. 12 T-bet (Tbx21), a novel member of the T-box family of transcription factors, is a key regulator of Th1 lineage commitment and is required for optimal production of IFN-␥ by CD4 ϩ T cells. 13 It is primarily induced in response to IFN-␥/Stat1 signaling, up-regulating expression of both IFN-␥ and the IL-12 receptor ␤2 chain (IL-12R␤2), thereby enabling IL-12-induced stabilization of IFN-␥ production and activation of the IL-18 signaling pathway. IL-12, 14 IL-15, 15 IL-21, 15 and IL-27 16, 17 have also been identified as being able to induce Tbet expression in CD4 ϩ T cells, whereas TGF-␤ is able to suppress T-bet expression. 18 Although its role in CD4 ϩ T cells has been most extensively investigated, T-bet is expressed in other immune cells, including CD8
ϩ T cells, 19 B cells, 20 dendritic cells, 21 and NK cells. 22 Glomerulonephritis (GN) is a common cause of end-stage kidney disease worldwide, and crescentic GN is the most injurious form. Evidence from human and experimental forms of crescentic GN suggests that crescent formation is driven by a Th1-predominant nephritogenic immune response. [23] [24] [25] In patients with systemic lupus erythematosus, T-bet expression in the urine and kidneys of patients correlates with clinically and histologically active lupus nephritis. 26 Studies in T-betdeficient, lupus-prone mice have found that T-bet is dispensable for the development of T cell-mediated autoimmune manifestations (such as salivary gland and hepatic infiltrates) but is required for IgG class switching, pathogenic autoantibody production, and the development of immune-complex GN. 27 Intrarenal expression of T-bet in human renal biopsy specimens has been demonstrated to be predictive of functionally significant renal allograft rejection. 28 The hypothesis that T-bet plays a pathogenic role, via Th1 polarization of the immune response, in the development of anti-glomerular basement membrane (GBM) GN, a model that is driven by a CD4 ϩ Th1-predominant immune response directed toward a planted nephritogenic antigen, was addressed in T-bet Ϫ/Ϫ mice and C57BL/6, wild-type (WT) controls. Immune responses and renal injury were compared, and the involvement of Th17 cells was sought by measurement of immune and renal IL-17A mRNA expression.
RESULTS

T-bet Deficiency Confers Protection Against Renal Injury
Twenty-one days after intravenous injection with sheep antimouse GBM globulin, WT mice developed diffuse proliferative and crescentic GN with moderately severe tubulointerstitial damage ( As the nature and direction of the systemic immune response can influence the expression of glomerular disease, the systemic immune response to the nephritogenic antigen (i.e. sheep globulin) was measured. WT mice with GN developed significant antigen-specific humoral immune responses as assessed by circulating antibody levels. T-bet Ϫ/Ϫ mice with GN had higher titers of antigen-specific IgG and IgG 1 , but not IgG 3 ( Figure 4 ). Antigen-stimulated splenocyte production of IFN-␥ was markedly reduced in T-bet Ϫ/Ϫ mice, but there were no differences in IL-4, IL-5, IL-17A, or TGF-␤1 production ( Figure 5 , A through E). T-bet deficiency was associated with a trend toward reduction in dermal delayed-type hypersensitivity (DTH) to the nephritogenic antigen (P ϭ 0.05; Figure 5 , F). These results are consistent with a reduction in Th1 immunity.
Intrarenal mRNA Expression of Cytokines and Chemokines
To investigate mechanisms by which T-bet deficiency confers protection against renal injury in experimental crescentic GN, we analyzed the intrarenal mRNA expression of cytokines and chemokines by real-time polymerase chain reaction (PCR) and RNase protection assay. Compared with WT controls, expression of CCL5/RANTES and CXCL9/Mig was significantly reduced (Table 1) . These are potent Th1 chemoattractants, and their reduction was associated with reduced CD4 ϩ T cell accumulation. IFN-␥ and IL-4 mRNA expression in T-bet Ϫ/Ϫ mice Data are percentage of housekeeping gene (␤-actin for CXCL9/Mig and L32 for other chemokines). T-bet Ϫ/Ϫ mice had reduced intrarenal mRNA expression of CCL5/RANTES and CXCL9/Mig and increased CCL3/MIP-1␣ and CCL4/MIP-1␤. a P ϭ 0.0003.
was not significantly different, but IL-17A expression was increased ( Figure 6 ). In addition, expression of MIP-1␣ and Ϫ1␤ was increased (Table 1 ).
Temporal Expression of T-bet
Given the central role of T-bet in directing Th1 lineage commitment, we examined the nature of the immune response in experimental crescentic GN by analyzing the splenic mRNA expression of T-bet in WT mice throughout the course of the disease. T-bet expression in the spleen increased after administration of sheep anti-mouse GBM globulin, peaking at day 6 ( Figure 7) . The kinetic profile of T-bet mRNA expression in the kidney was similar (Figure 7 ).
Effect of T-bet Deficiency on CD4
؉ T Cell and CD19 To further dissect the mechanisms by which T-bet Ϫ/Ϫ mice are relatively protected from renal injury, we next examined immune responses at an earlier time point when adaptive immune responses are being established and when T-bet expression is greatest. Six days after administration of anti-GBM globulin, splenic CD4 ϩ T cell and CD19 ϩ B cell proliferation were diminished in T-bet Ϫ/Ϫ mice ( Figure 8 , A and B) with no ϩ T cell and CD19 ϩ B cell proliferation, apoptosis, and activation were assessed by flow cytometric analysis of in vivo bromodeoxyuridine (BrdU) incorporation, Annexin-V (An-V) staining, and CD69 expression, respectively, 6 d after administration of anti-GBM globulin. In comparison to WT controls, T-bet Ϫ/Ϫ mice exhibited reduced proliferation of CD4 ϩ T cells (A) and CD19 ϩ B cells (B) with no effect on apoptosis (C and D). There were less activated splenic CD4 ϩ T cells (E), but not CD19 ϩ B cells (F), in T-bet Ϫ/Ϫ mice compared with WT mice. *P Ͻ 0.05, ***P Ͻ 0.001. (Figure 9 ). Expression of CXCR3, a chemokine receptor that is preferentially expressed on Th1 cells, was diminished in T-bet Ϫ/Ϫ mice compared with WT controls, while expression of CCR1 was augmented (Table 2) .
Histologic Renal Injury at Earlier Time Points
We also examined histologic renal injury 1 d (during the heterologous phase of nephritis) and 6 d following intravenous injection with sheep anti-mouse GBM globulin. Compared with WT controls, T-bet Ϫ/Ϫ mice had similar numbers of abnormal glomeruli, glomerular and interstitial CD4 ϩ T cells, and glomerular macrophages, and a similar degree of tubulointerstitial injury and inflammation (Table 3) .
DISCUSSION
In planted antigen models of GN, CD4
ϩ T helper cells play a critical role in both the initiation of the nephritogenic immune response 29 and the effector phase of the disease. 25, 30 The Th1/ Th2 bias of the CD4 ϩ T cell response also affects the pattern and extent of glomerular injury such that deficiency or neutralization of Th1 or Th2 cytokines leads to amelioration or exacerbation of disease, respectively. 25, [31] [32] [33] [34] [35] Significant evidence therefore suggests that crescentic GN is driven by a CD4 ϩ , Th1-directed nephritogenic immune response. Transcription factors play a pivotal role in determining immune cell fate and function and most likely exert significant influence on the development of crescentic GN.
These studies investigated the role of T-bet in autologous phase, anti-GBM GN, a Th1-driven model of crescentic GN. T-bet Ϫ/Ϫ mice were protected from renal injury, both functionally (proteinuria) and histologically (glomerular crescents, tubulointerstitial inflammation and infiltration with glomerular CD4 ϩ T cells and macrophages and interstitial CD4 ϩ T cells). These results indicate that T-bet plays an important pathogenic role in the development of autologous phase, anti-GBM GN.
T-bet plays a key role in the development and maintenance of Th1 cells, the signature cytokine of which is IFN-␥. In our study, T-bet deficiency was associated with a marked reduction in splenocyte production of IFN-␥ but with no effect on IL-4, IL-5, or TGF-␤1 production. There was a trend toward diminished dermal DTH to the nephritogenic antigen (P ϭ 0.05). Humoral responses were augmented in T-bet Ϫ/Ϫ mice, as indicated by elevated titers of circulating IgG and IgG 1 with no difference in IgG 3 production. Supporting the pro-inflammatory nature of the T-bet signaling pathway, T-bet deficiency was associated with reduced CD4 ϩ T cell proliferation and activation. We also analyzed the kinetic profile of T-bet mRNA expression in WT mice and found that splenic and intrarenal Table 3 . Histologic renal injury in WT and T-bet Ϫ/Ϫ mice 1 and 6 days after injection of sheep anti-mouse GBM globulin BASIC RESEARCH www.jasn.org mRNA expression of T-bet was increased throughout the course of experimental crescentic GN, peaking at the 6 d time point. These findings are consistent with the central role of T-bet in polarizing naïve CD4 ϩ T cells to a Th1 phenotype, a process that tends to occur relatively early in the adaptive immune response and supports the evidence that experimental crescentic GN is directed by Th1 nephritogenic immunity. Taken together, these results suggest that one mechanism by which T-bet deficiency abrogates renal injury is by skewing the Th1/Th2 balance away from a Th1 phenotype.
Chemokines play an important role in the recruitment of injurious CD4 ϩ T cells into the inflamed kidney. 36 We analyzed the mRNA expression of chemokines in the kidney and chemokine receptors in the spleen to investigate mechanisms of leukocyte recruitment and renal injury in the absence of T-bet. There was a significant reduction in intrarenal mRNA expression of the CD4 ϩ Th1 cell chemoattractants, CCL5/RANTES and CXCL9/Mig. Reduced splenic mRNA expression of CXCR3 and reduced CD4 ϩ T cell proliferation and activation suggests that T-bet deficiency led to reduced Th1 effectors. These 2 observations are likely to explain the reduced accumulation of Th1 effectors in the kidneys of T-bet Ϫ/Ϫ mice. T-bet deficiency was also associated with increased intrarenal mRNA expression of CCL3/MIP-1␣ and CCL4/MIP-1␤. The biologic significance of this is uncertain but, given that CCL3/MIP-1␣ and CCL4/MIP-1␤ are neutrophil chemoattractants, their up-regulation could conceivably explain the persistence of glomerular neutrophils despite a reduction in CD4 ϩ T cells and macrophages. Recent evidence indicates that T-bet plays a pathogenic role in experimental models of other Th1-type diseases, including inflammatory bowel disease 37, 38 and experimental autoimmune encephalomyelitis. 39 Th17 cells, a recently identified subset of T helper cells, are characterized by the production of IL-17A (in addition to IL-6 and granulocyte macrophage colony stimulating factor) and have also been implicated in the pathogenesis of autoimmune disease. 9 Development of Th17 cells occurs in the presence of IL-6 and TGF-␤ 9,40 while their growth and survival are dependent on IL-23. In our study, T-bet Ϫ/Ϫ mice had enhanced mRNA expression of the pro-inflammatory cytokine, IL-17A, both locally (in the kidney) and systemically (in the spleen), suggesting that its expression is counter-regulated by T-bet signaling in this form of GN. In GN, the precise role of IL-17A and Th17 cells remains to be defined.
In summary, these studies indicate that endogenous T-bet directs injurious, nephritogenic, Th1 responses and promotes the development of renal injury in experimental crescentic GN.
CONCISE METHODS
Experimental Design
T-bet
Ϫ/Ϫ mice on a C57BL/6 background were obtained from the Jackson Laboratory (Bar Harbor, ME) and bred at Monash Medical Centre (Melbourne, Australia). C57BL/6, WT mice were obtained from Monash Animal Services (Melbourne, Australia). Sheep antimouse GBM globulin was prepared as described previously. 31 Nonaccelerated, autologous phase, anti-GBM GN was induced in agematched, 10-to 12-wk-old, male mice by intravenous administration of 20 mg sheep anti-mouse GBM globulin (day 0). Immune responses, renal injury, and mRNA expression of T-bet were assessed on days 1, 6, and 21 in T-bet Ϫ/Ϫ (n ϭ 4, 7, and 8, respectively) and WT (n ϭ 4, 8, and 7, respectively) mice. Studies were approved by the Monash University Animal Ethics Committee and performed in accordance with the National Health and Medical Research Council of Australia guidelines. Results are expressed as means Ϯ SEM. Unpaired t test was used for statistical analysis (GraphPad Prism; GraphPad Software, San Diego, CA). Differences were considered to be statistically significant if P Ͻ 0.05.
Assessment of Renal Injury
Glomerular abnormalities were assessed on PAS-stained, Bouin'sfixed, 3-m-thick, paraffin-embedded sections. Abnormalities included crescent formation (considered to be apparent when glomeruli exhibited 2 or more layers of cells in Bowman's space), segmental proliferation, necrosis, hyalinosis, or capillary wall thickening. The proportion of glomeruli affected was determined by examining a minimum of 50 glomeruli per mouse for abnormalities, as previously published. 41 Urine was collected, using metabolic cages, during the 24-h period before death, and serum was obtained from blood collected on the day of death. Serum and urine creatinine concentrations were measured by an enzymatic creatininase assay. Proteinuria was determined by a modified Bradford method 42 and expressed as milligrams per micromols of creatinine. , and the secondary antibody used was rabbit anti-rat biotin (BD Biosciences). Endogenous biotin was blocked using a biotinblocking system (Dako, Botany, Australia), and CD4 ϩ T cells and macrophages were detected using an avidin-biotin complex detection system (Dako). A minimum of 20 consecutively viewed glomeruli and a minimum of 10 high-power cortical interstitial fields (excluding perivascular regions) were assessed per animal, and results expressed as cells per glomerular cross section (c/gcs) or cells per high-power filed (c/hpf), as described previously. 35 Semiquantitative analysis of tubulointerstitial damage was performed on PAS-stained sections and scored according to previously described criteria. 43 Ten randomly selected cortical areas from each animal were examined at ϫ200 magnification using a 10-mm 2 graticule. Tubulointerstitial injury was defined as tubular dilation, tubular atrophy, sloughing of tubular epithelial cells, or thickening of the basement membrane. Interstitial inflammation was defined according to the degree of leukocytic infiltration in the interstitium. Tubu-lointerstitial injury and interstitial inflammation were each assessed separately and graded according to a scale of 0 to 4: grade 0, no tubulointerstitial injury, no interstitial inflammation; grade 1, less than 25% of the tubulointerstitium injured, minimal tubulointerstitial inflammation; grade 2, 25% to 50% of the tubulointerstitium injured, mild tubulointerstitial inflammation; grade 3, 51% to 75% of the tubulointerstitium injured, moderate tubulointerstitial inflammation; grade 4, more than 75% of the tubulointerstitium injured, diffuse tubulointerstitial inflammation.
Splenocyte Cytokine Production and Dermal DTH
Spleens were aseptically removed from mice and single-cell suspensions obtained. Splenocytes (4 ϫ 10 6 cells/ml per well) were cultured in RPMI/10% FCS with protein G-purified normal sheep IgG (10 g/ml) for 72 h at 37°C. Concentrations of IFN-␥, IL-4, and IL-5 in splenocyte supernatants were measured by ELISA, as described previously. 35, 44 The antibodies used were rat anti-mouse IFN-␥ (R4 -6A2; BD Pharmingen, San Diego, CA), biotinylated rat anti-mouse IFN-␥ (XMG1.2; BD Pharmingen), rat anti-mouse IL-4 (11B11; ATCC), biotinylated rat anti-mouse IL-4 (BVD6; DNAX Research Institute, Palo Alto, CA), rat anti-mouse IL-5 (TRFK5; R&D systems, Minneapolis, MN), and biotinylated rat anti-mouse IL-5 (TRFK4; R&D systems). Concentrations of IL-17A and TGF-␤1 were measured by ELISA using an IL-17 DuoSet and TGF-␤1 ELISA kit (R&D Systems), respectively, as per the manufacturer's protocol. To measure dermal DTH, mice were challenged by intradermal injection of 0.5 mg of sheep globulin into the left plantar footpad or the same dose of horse globulin as an irrelevant control antigen into the contralateral footpad, 24 h before the end of experiments. DTH was quantified 24 h later by measurement of the difference in footpad thickness (⌬mm) using a micrometer (Mitutoyo, Kawasaki-shi, Japan).
Circulating Antigen-Specific Antibody Levels
Circulating serum antigen-specific Ig titers were assessed by ELISA as described previously, 44 Renal and Splenic mRNA Expression of T-bet, Cytokines, Chemokines, and Chemokine Receptors
Spleens and kidneys were obtained from T-bet Ϫ/Ϫ and WT mice before and on days 1, 6, and 21 after administration of sheep anti-mouse GBM globulin to assess the kinetic profile of T-bet mRNA expression. Six days after injection of sheep anti-mouse GBM globulin, spleens were obtained from T-bet Ϫ/Ϫ and WT mice to assess mRNA expression of cytokines and chemokine receptors. Twenty-one days after administration of sheep anti-mouse GBM globulin, kidneys were obtained from T-bet Ϫ/Ϫ and WT mice to assess mRNA expression of cytokines and chemokines. Splenic and intrarenal RNA was prepared and assessed for expression of chemokine receptors and chemokines using the RiboQuant RNase protection assay system (BD Pharmingen; template sets mCR-5, including template for CXCR3, and mCK-5c, respectively), as described previously. 47 Results are expressed as percentage, relative to the housekeeping gene, L32, as previously published. 47 For measurement of splenic and intrarenal mRNA expression of IFN-␥, IL-4, IL-17A, Mig, T-bet, and ␤-actin by real-time PCR, 500 ng of RNA from each sample was treated with 1 unit of amplification-grade DNase I (Invitrogen, Mount Waverley, Australia), primed with 500 ng of oligo(dT) 12 to 18 (Roche, Mannheim, Germany) and reverse transcribed using Superscript III RT (Invitrogen). Gene-specific oligonucleotide primers were designed with Primer3 software (Whitehead Institute for Biomedical Research, Cambridge, MA) 48 and synthesized by Invitrogen (Table 4) . Real-time PCR was performed on a Rotor Gene RG-3000 (Corbett Research, Mortlake, Australia) using FastStart DNA master, Sybr Green I (Roche). PCR products were confirmed by melt-curve analysis, and mRNA expression was quantified using serial dilutions of an exogenous standard. Results are expressed as percentage, relative to the housekeeping gene, ␤-actin.
